Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
(By Emmarie Huetteman and Jay Hancock for Kaiser Health News) Expect sparks to fly Tuesday as senators get a rare
Read More
Part D/Prescription Drugs
In Florida, Drug Re-Importation From Canada Finds New Champions, Old Snags
(By Shefali Luthra and Phil Galewitz for Kaiser Health News) Florida Gov. Ron DeSantis said Wednesday he intends to bring
Read MoreTalk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
(By Jay Hancock for Kaiser Health News) Kenneth Frazier, CEO of pharma giant Merck, is set to face senators Tuesday
Read MorePurdue’s Sackler embraced plan to conceal OxyContin’s strength from doctors, sealed deposition shows
(By David Armstrong for a collaboration between STAT and ProPublica) I n May 1997, the year after Purdue Pharma launched
Read MoreSupplies of bladder cancer drug are dwindling
(By Alia Paavola for Becker’s Hospital Review ) Supplies of BCG, a critical immunotherapy drug that treats bladder cancer, are
Read MoreDrug spending could rise 6.1 percent annually by 2020, federal projections show
(By Ike Swetlitz for ST A T) W ASHINGTON — Spending on prescription drugs is expected to increase at an
Read MoreMore States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
(By Barbara Feder Ostrov for California Healthline produced by Kaiser Health News) In a growing number of states, patients who
Read MoreCMS can terminate private Medicare plans with poor Star Ratings again
(By Morgan Haefner for Becker’s Hospital Review ) CMS informed Medicare Advantage and Part D drug plans that it will
Read MoreWith one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling
(By Meghana Keshavan for ST A T) B ob Field was set to kick off his second course of BCG
Read More‘Everyone is at fault’: With insulin prices skyrocketing, there’s plenty of blame to go around
(By Nicholas Florko for ST A T) W ASHINGTON — Fifteen years ago, a patient with diabetes might have paid
Read More